Bayer shareholder Harris backs CEO focus on internal restructuring
In a written response to a Reuters request for comment, Herro said the CEO was rightly focusing on efforts to "turn three very good businesses into great businesses".
Frankfurt: Major Bayer shareholder Harris Associates on Thursday came out in strong support of the drugmaker's decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.The endorsement buoyed Bayer's shares, taking some pressure off Chief Executive Bill Anderson, who on Tuesday said he will pause for up to three years considerations to...
Frankfurt: Major Bayer shareholder Harris Associates on Thursday came out in strong support of the drugmaker's decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.
The endorsement buoyed Bayer's shares, taking some pressure off Chief Executive Bill Anderson, who on Tuesday said he will pause for up to three years considerations to break apart the group to focus on problems including debt and litigation.
Read also: Bayer to hold off on plans to break apart group for up to 3 years
Original news source: https://www.reuters.com/business/healthcare-pharmaceuticals/major-bayer-shareholder-harris-backs-ceos-focus-internal-restructuring-2024-03-07/
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd